Remove Business Remove DEA Remove Safety
article thumbnail

Intoxicating Hemp Swindle

Project CBD

Devitt expresses serious safety concerns. In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis. However, the following year the DEA put off its decision pending further public commentary. Theres no ambiguity or loophole.

Hemp 232
article thumbnail

Congressional Committee to Hold Marijuana Legislative Hearing This Wednesday

NORML

The legislative hearing notice states that six bills will be discussed, including HR 3884 , the MORE Act, which recently was approved in the House Judiciary Committee by a bipartisan vote of 24-10 and waived by the House Small Business Committee. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

USDA NON-ENFORCEMENT OF DEA-LAB AND DISPOSAL REQUIREMENTS

Cannabis Law Report

After a significant outcry by the hemp community, the USDA is backing down from its requirement that all hemp be tested at DEA-registered labs for the 2020 season. However, hemp producers should be aware that the USDA expects to begin enforcing the requirement to use DEA-registered labs for the 2021 growing season.

DEA 59
article thumbnail

The Week in Weed: August 28, 2020

The Blunt Truth

The DEA has a new hemp rule. Governor Tom Wolf (D) is calling on the legislature to pass a legalization bill, indicating that the proceeds for sales will help ease the financial strain of the pandemic on small businesses. dea hemp rule. He did not address the DEA’s new rule and its effect on the industry’s survival.

DEA 109
article thumbnail

Is The DEA Poised To Regulate Telepharmacy?

Cannabis Law Report

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52
article thumbnail

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

Cannabis Law Report

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and other psychoactive substances, and manufactures multiple commercial Cannabidiol (CBD) products in compliance with the 2018 U.S. OXNARD, Calif.–(BUSINESS

article thumbnail

The Ketamine Clinic Craze: Legalities and Possibilities

Canna Law Blog

There are questions about the logistics of opening and running one of these types of businesses, given the complex interplay of laws and regulations promulgated by bodies from the U.S. Still, for all its promise, would-be clinic owners, practitioners, and consumers may be confused about the legality of such clinics.

Therapy 104